Generate a tailored SOP for Dr. Jesus Rodriguez Manzano. Improve your application with a focused, well-structured draft.
Dr. Jesus Rodriguez Manzano leads a group focused on developing and implementing innovative methods for molecular diagnosis of infectious diseases and antimicrobial resistance (AMR). His work integrates hardware, software, and molecular science to create technologies that can fundamentally transform the field of medicine by facilitating rapid diagnosis in diverse environments. Dr. Rodriguez Manzano's research addresses urgent threats posed by drug-resistant pathogens, particularly in resource-limited settings. His team's current research focuses on four key areas: (1) development of molecular-based diagnostic devices for point-of-care applications; (2) application of machine learning approaches to enhance diagnostic capabilities; (3) validation of frameworks for biomarker discovery; and (4) understanding underlying mechanisms of amplification reactions to improve analytical performance. He also plays an active role in national responses to public health challenges such as COVID-19. With over 100 scientific publications and 15 international patent applications, Dr. Rodriguez Manzano is recognized as a leader in the intersection of molecular diagnostics and antimicrobial resistance.
Centre Antimicrobial Optimisation (CAMO) • Imperial College London
Co-founder and Chief Scientific Officer at ProtonDx.
Imperial College London, Department of Infectious Disease • London, United Kingdom
Imperial College London, Department of Infectious Disease • United Kingdom
Imperial College London, Department of Infectious Disease • London, United Kingdom
Specialisms available in Materials for the Energy Transition or Theory and Simulation of Materials.